Cargando…

Recurrent Novel P2RY8/IGH Translocations in B-Lymphoblastic Leukemia/Lymphoma

Translocations involving the immunoglobulin heavy chain (IGH) locus are common abnormalities in B-lymphoblastic leukemia/lymphoma (B-ALL) and multiple myeloma. These rearrangements result in a juxtaposition of IGH enhancers to the vicinity of oncogenes, such as MYC and CRLF2, leading to the upregula...

Descripción completa

Detalles Bibliográficos
Autores principales: Fang, Yanglan, Wang, Man, Hu, Shuhong, Wang, Tanzhen, Liu, Yujie, Xiao, Jinyan, Cai, Yiming, Wang, Ying, Qiu, Huiying, Tang, Xiaowen, Chen, Suning, Wu, Depei, Xu, Yang, Liu, Tianhui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330356/
https://www.ncbi.nlm.nih.gov/pubmed/35912172
http://dx.doi.org/10.3389/fonc.2022.896858
_version_ 1784758140694167552
author Fang, Yanglan
Wang, Man
Hu, Shuhong
Wang, Tanzhen
Liu, Yujie
Xiao, Jinyan
Cai, Yiming
Wang, Ying
Qiu, Huiying
Tang, Xiaowen
Chen, Suning
Wu, Depei
Xu, Yang
Liu, Tianhui
author_facet Fang, Yanglan
Wang, Man
Hu, Shuhong
Wang, Tanzhen
Liu, Yujie
Xiao, Jinyan
Cai, Yiming
Wang, Ying
Qiu, Huiying
Tang, Xiaowen
Chen, Suning
Wu, Depei
Xu, Yang
Liu, Tianhui
author_sort Fang, Yanglan
collection PubMed
description Translocations involving the immunoglobulin heavy chain (IGH) locus are common abnormalities in B-lymphoblastic leukemia/lymphoma (B-ALL) and multiple myeloma. These rearrangements result in a juxtaposition of IGH enhancers to the vicinity of oncogenes, such as MYC and CRLF2, leading to the upregulation of oncogenes. Here, we identified recurrent novel P2RY8/IGH translocations in three B-ALL patients by transcriptome sequencing. Noncoding exon 1 of P2RY8 was translocated to different sites of the IGH gene, resulting in transcripts of P2RY8/IGHM, P2RY8/IGHV, and P2RY8/IGHD. However, a high expression level of truncated P2RY8 was observed in the patients compared with healthy donors, which might be related to the aggressive clinical course and inferior outcome. In summary, we described recurrent novel P2RY8/IGH translocations with high expression levels of P2RY8, which may contribute to the guidelines for clinical diagnosis and treatment.
format Online
Article
Text
id pubmed-9330356
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-93303562022-07-29 Recurrent Novel P2RY8/IGH Translocations in B-Lymphoblastic Leukemia/Lymphoma Fang, Yanglan Wang, Man Hu, Shuhong Wang, Tanzhen Liu, Yujie Xiao, Jinyan Cai, Yiming Wang, Ying Qiu, Huiying Tang, Xiaowen Chen, Suning Wu, Depei Xu, Yang Liu, Tianhui Front Oncol Oncology Translocations involving the immunoglobulin heavy chain (IGH) locus are common abnormalities in B-lymphoblastic leukemia/lymphoma (B-ALL) and multiple myeloma. These rearrangements result in a juxtaposition of IGH enhancers to the vicinity of oncogenes, such as MYC and CRLF2, leading to the upregulation of oncogenes. Here, we identified recurrent novel P2RY8/IGH translocations in three B-ALL patients by transcriptome sequencing. Noncoding exon 1 of P2RY8 was translocated to different sites of the IGH gene, resulting in transcripts of P2RY8/IGHM, P2RY8/IGHV, and P2RY8/IGHD. However, a high expression level of truncated P2RY8 was observed in the patients compared with healthy donors, which might be related to the aggressive clinical course and inferior outcome. In summary, we described recurrent novel P2RY8/IGH translocations with high expression levels of P2RY8, which may contribute to the guidelines for clinical diagnosis and treatment. Frontiers Media S.A. 2022-07-14 /pmc/articles/PMC9330356/ /pubmed/35912172 http://dx.doi.org/10.3389/fonc.2022.896858 Text en Copyright © 2022 Fang, Wang, Hu, Wang, Liu, Xiao, Cai, Wang, Qiu, Tang, Chen, Wu, Xu and Liu https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Oncology
Fang, Yanglan
Wang, Man
Hu, Shuhong
Wang, Tanzhen
Liu, Yujie
Xiao, Jinyan
Cai, Yiming
Wang, Ying
Qiu, Huiying
Tang, Xiaowen
Chen, Suning
Wu, Depei
Xu, Yang
Liu, Tianhui
Recurrent Novel P2RY8/IGH Translocations in B-Lymphoblastic Leukemia/Lymphoma
title Recurrent Novel P2RY8/IGH Translocations in B-Lymphoblastic Leukemia/Lymphoma
title_full Recurrent Novel P2RY8/IGH Translocations in B-Lymphoblastic Leukemia/Lymphoma
title_fullStr Recurrent Novel P2RY8/IGH Translocations in B-Lymphoblastic Leukemia/Lymphoma
title_full_unstemmed Recurrent Novel P2RY8/IGH Translocations in B-Lymphoblastic Leukemia/Lymphoma
title_short Recurrent Novel P2RY8/IGH Translocations in B-Lymphoblastic Leukemia/Lymphoma
title_sort recurrent novel p2ry8/igh translocations in b-lymphoblastic leukemia/lymphoma
topic Oncology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9330356/
https://www.ncbi.nlm.nih.gov/pubmed/35912172
http://dx.doi.org/10.3389/fonc.2022.896858
work_keys_str_mv AT fangyanglan recurrentnovelp2ry8ightranslocationsinblymphoblasticleukemialymphoma
AT wangman recurrentnovelp2ry8ightranslocationsinblymphoblasticleukemialymphoma
AT hushuhong recurrentnovelp2ry8ightranslocationsinblymphoblasticleukemialymphoma
AT wangtanzhen recurrentnovelp2ry8ightranslocationsinblymphoblasticleukemialymphoma
AT liuyujie recurrentnovelp2ry8ightranslocationsinblymphoblasticleukemialymphoma
AT xiaojinyan recurrentnovelp2ry8ightranslocationsinblymphoblasticleukemialymphoma
AT caiyiming recurrentnovelp2ry8ightranslocationsinblymphoblasticleukemialymphoma
AT wangying recurrentnovelp2ry8ightranslocationsinblymphoblasticleukemialymphoma
AT qiuhuiying recurrentnovelp2ry8ightranslocationsinblymphoblasticleukemialymphoma
AT tangxiaowen recurrentnovelp2ry8ightranslocationsinblymphoblasticleukemialymphoma
AT chensuning recurrentnovelp2ry8ightranslocationsinblymphoblasticleukemialymphoma
AT wudepei recurrentnovelp2ry8ightranslocationsinblymphoblasticleukemialymphoma
AT xuyang recurrentnovelp2ry8ightranslocationsinblymphoblasticleukemialymphoma
AT liutianhui recurrentnovelp2ry8ightranslocationsinblymphoblasticleukemialymphoma